Evidence map›Paper›PMID 26573300›Full record

ArticleJournal of gastroenterology2016

Long-term outcomes after treatment for pedunculated-type T1 colorectal carcinoma: a multicenter retrospective cohort study.

Naoki Asayama, Shiro Oka, Shinji Tanaka, Shinji Nagata, Akira Furudoi, Toshio Kuwai, Seiji Onogawa, Tadamasa Tamura, Hiroyuki Kanao, Yuko Hiraga and 7 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Naoki AsayamaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Shiro OkaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan. oka4683@hiroshima-u.ac.jp.
Shinji TanakaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Shinji NagataDepartment of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan.
Akira FurudoiDepartment of Gastroenterology, JA Hiroshima General Hospital, Hiroshima, Japan.
Toshio KuwaiDepartment of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Seiji OnogawaDepartment of Gastroenterology, Onomichi General Hospital, Hiroshima, Japan.
Tadamasa TamuraDepartment of Internal Medicine, Hiroshimakinen Hospital, Hiroshima, Japan.
Hiroyuki KanaoDepartment of Gastroenterology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
Yuko HiragaDepartment of Endoscopy, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Hideharu OkanobuDepartment of Gastroenterology, Chugoku Rosai Hospital, Hiroshima, Japan.
Takayasu KuwabaraDepartment of Gastroenterology, Shobara Red Cross Hospital, Hiroshima, Japan.
Masaki KunihiroDepartment of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Shinichi MukaiDepartment of Gastroenterology, Miyoshi Central Hospital, Hiroshima, Japan.
Eizo GotoDepartment of Gastroenterology, Higashihiroshima Medical Center, Hiroshima, Japan.
Fumio ShimamotoDepartment of Health Science, Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima, Japan.
Kazuaki ChayamaDepartment of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe risk for lymph node metastasis and the prognostic significance of pedunculated-type T1 colorectal carcinomas (CRCs) require further study. We aimed to assess the validity of the 2014 Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines based on long-term outcomes of pedunculated-type T1 CRCs.

methodsIn this multicenter retrospective cohort study, we examined 176 patients who underwent resection endoscopically or surgically at 14 institutions between January 1990 and December 2010. Patients meeting the JSCCR curative criteria were defined as "endoscopically curable (e-curable)" and those who did not were "non-e-curable". We evaluated the prognosis of 116 patients (58 e-curable, 58 non-e-curable) who were observed for >5 years after treatment.

resultsOverall incidence of lymph node metastasis was 5 % (4/81; 95 % confidence interval 1.4-12 %: three cases of submucosal invasion depth ≥1000 μm [stalk invasion] and lymphatic invasion, one case of head invasion and budding grade 2/3). There was no local or metastatic recurrence in the e-curable patients, but six of them died of another cause (observation period, 80 months). There was no local recurrence in the non-e-curable patients; however, distant metastasis was observed in one patient. Death due to the primary disease was not observed in non-e-curable patients, but six of them died of another cause (observation period, 72 months).

conclusionsOur data support the validity of the JSCCR curative criteria for pedunculated-type T1 CRCs. Endoscopic resection cannot be considered curative for pedunculated-type T1 CRC with head invasion alone.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overColonic NeoplasmsDisease-Free SurvivalEndoscopyFemaleHumansMaleMiddle AgedNeoplasm InvasivenessRectal NeoplasmsRetrospective StudiesTreatment OutcomeClinicopathological characteristicsLymph node metastasisOutcomesPedunculated-type T1 colorectal carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.